Resverlogix Corp T.RVX

Alternate Symbol(s): RVXCF

Healthcare Biotechnology

Resverlogix Corp. is a Canada-based late-stage biotechnology company. The Company is engaged in epigenetics, with a focus on developing therapies for the benefit of patients with chronic diseases. Its epigenetic therapies are designed to regulate the expression of disease-causing genes. The Company's clinical program is focused on evaluating its lead candidate apabetalone (RVX-208) for the treatment of cardiovascular disease and associated comorbidities, and post-COVID-19 conditions. RVX-208 is a small molecule that is a selective bromodomain and extra-terminal (BET) inhibitor. BET bromodomain inhibition is an epigenetic mechanism that can regulate disease-causing genes. RVX-208 is a BET inhibitor selective for the second bromodomain (BD2) within the BET proteins. It partners with EVERSANA, to support the commercialization of RVX-208 for cardiovascular disease, post-COVID-19 conditions, and pulmonary arterial hypertension in Canada and the United States.

TSX:RVX - Post by User

Resverlogix Corp

Bullboard Posts

Comment by fuzzyjron Aug 15, 2018 10:38am

135 Views

Post# 28464311

RE:RE:Feeling depressed maybe? Look at this chart:

“Led..lets hope it holds at this level into the new year and
the reverse split may end up 1 for 2.”

cant imagine very many people being satisfied if we “hold at this level” & happy about settling for a “1 for 2” Wow, that’s brutal IMO.

many things can & will happy in the coming weeks & months. You goin be happy with a 3 buck sp from now until Xmas!!! I sure won’t be & never even considered 3 bucks or so up to the new year to be a good thing - in fact if that’s all we can muster up were in trouble IMO
glta

Bullboard Posts

Buzz on the Bullboards: Tech gains amid weak commodities